• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Garry Nicholson - Articles and news items

Pfizer logo

Pfizer announces submission of palbociclib New Drug Application to the FDA

Industry news / 19 August 2014 / Pfizer

Pfizer Inc. announced it has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administration for palbociclib…

Pfizer logo

U.S. Food and Drug Administration approves BOSULIF® (bosutinib)

Industry news, News / 4 September 2012 / Pfizer

“BOSULIF is the third new medicine to be approved by the FDA in just 13 months…”

Pfizer logo

Pfizer announces FDA acceptance of New Drug Application for Bosutinib

Industry news, News / 27 January 2012 / Pfizer

The U.S. FDA has accepted its NDA for standard review of bosutinib…

Pfizer logo

U.S. Food and Drug Administration approves Pfizer’s INLYTA® (axitinib)

Industry news, News / 27 January 2012 / Pfizer

First treatment to demonstrate superior benefit in a Phase 3 study compared with another targeted agent in advanced RCC…

Pfizer logo

SFJ Pharma Ltd. II announces agreement with Pfizer to develop Axitinib

Industry news, News / 9 January 2012 / Citigate Dewe Rogerson

SFJ announced that it has entered into a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial…

Pfizer logo

Pfizer files with the FDA for review of Axitinib for patients with advanced RCC

Industry news, News / 28 June 2011 / Pfizer

The U.S. FDA has accepted Pfizer’s filing for standard review of axitinib for patients with advanced RCC…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +